Theerapong Krajaejun Selected Research

Pythiosis

2/2022	Global Distribution and Clinical Features of Pythiosis in Humans and Animals.
9/2021	History and Perspective of Immunotherapy for Pythiosis.
6/2021	Immunological Cross-Reactivity of Proteins Extracted from the Oomycete Pythium insidiosum and the Fungus Basidiobolus ranarum Compromises the Detection Specificity of Immunodiagnostic Assays for Pythiosis.
5/2021	Prospecting Biomarkers for Diagnostic and Therapeutic Approaches in Pythiosis.
6/2020	Expression, purification, and characterization of the recombinant exo-1,3-β-glucanase (Exo1) of the pathogenic oomycete Pythium insidiosum.
5/2020	Automated Cell-Free Multiprotein Synthesis Facilitates the Identification of a Secretory, Oligopeptide Elicitor-Like, Immunoreactive Protein of the Oomycete Pythium insidiosum.
4/2020	Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum.
1/2020	Recent update in diagnosis and treatment of human pythiosis.
4/2019	Seroprevalence of anti--Pythium insidiosum antibodies in the Thai population.
1/2019	The Repurposed Drug Disulfiram Inhibits Urease and Aldehyde Dehydrogenase and Prevents In Vitro Growth of the Oomycete Pythium insidiosum.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theerapong Krajaejun Research Topics

Disease

22	Pythiosis 02/2022 - 03/2002
6	Infections 05/2022 - 09/2006
2	Margins of Excision 01/2020 - 06/2018
2	Thalassemia 07/2009 - 05/2006
2	Communicable Diseases (Infectious Diseases) 07/2009 - 05/2006
1	Mycoses (Diseases, Fungus) 02/2022
1	entomophthoromycosis 06/2021
1	Asymptomatic Infections 04/2019
1	Alcoholism (Alcohol Abuse) 01/2019
1	Keratitis 01/2014
1	Blastomycosis 05/2011
1	Inflammation (Inflammations) 05/2011
1	Fever (Fevers) 05/2011
1	Vascular Diseases (Vascular Disease) 09/2006
1	Arteritis 05/2006
1	Ulcer 05/2006

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2009
5	AntigensIBA 05/2021 - 05/2006
4	VaccinesIBA 06/2020 - 05/2006
3	Peptides (Polypeptides)IBA 06/2021 - 08/2010
3	AntibodiesIBA 05/2021 - 07/2009
3	Complex MixturesIBA 06/2020 - 08/2010
3	EnzymesIBA 05/2013 - 03/2002
3	ImmunosorbentsIBA 05/2013 - 03/2002
2	Anti-Infective Agents (Microbicides)IBA 06/2020 - 08/2010
2	Pharmaceutical PreparationsIBA 04/2020 - 01/2019
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Disulfiram (Antabuse)FDA Link 01/2019
1	Antifungal AgentsIBA 01/2017
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2017
1	Terbinafine (Lamisil)FDA LinkGeneric 01/2017
1	Staphylococcal Protein A (Protein A)IBA 08/2016
1	ParaffinIBA 01/2014
1	peptide BIBA 07/2013
1	EpitopesIBA 07/2013
1	peptide AIBA 07/2013
1	Virulence Factors (Pathogenicity Factors)IBA 05/2011
1	Attenuated VaccinesIBA 05/2011
1	Antinuclear AntibodiesIBA 07/2009
1	DNA (Deoxyribonucleic Acid)IBA 03/2007
1	Immunodominant EpitopesIBA 05/2006

Therapy/Procedure

3	Surgical Amputation (Amputations) 06/2018 - 05/2006
2	Treatment Delay 02/2022 - 09/2006
1	Immunotherapy 09/2021
1	Penetrating Keratoplasty 01/2020
1	Debridement 05/2013